ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CircSETDB1 contributes to paclitaxel resistance of ovarian cancer cells by sponging miR-508-3p and regulating ABCC1 expression

Huang, Chunyan; Qin, Li; Chen, Sailan; Huang, Qin*1
Anti-Cancer Drugs2023-3DOI: 10.1097/CAD.0000000000001465
2被引8阅读
引用收藏
分享

摘要

Ovarian cancer is a gynecological tumor with a poor prognosis. The chemotherapy failure and recurrence induced by paclitaxel (Ptx) resistance are the main reason for the failure of ovarian cancer treatment. In this study, we aimed to explore the role of circular RNA (circRNA) in the regulation of Ptx resistance in ovarian cancer. Quantitative reverse transcription PCR was performed to detect the expression of circRNA SET domain bifurcated histone lysine methyltransferase 1 (circSETDB1), microRNA (miR)-508-3p and ATP-binding cassette subfamily C member 1 (ABCC1) mRNA. The effects of circSETDB1 on Ptx resistance were explored by cell counting kit-8, 5-ethynyl-2 '-deoxyuridine, and flow cytometry experiments in vitro. The protein level was assessed by western blot. Dual-luciferase reporter and RNA pull-down assays were carried out to confirm the interactions among circSETDB1, miR-508-3p, and ABCC1. Xenograft tumor experiment was performed to investigate the effect of circSETDB1 on Ptx resistance in vivo. CircSETDB1 was highly expressed in Ptx-resistant ovarian cancer. CircSETDB1 knockdown inhibited cell proliferation viability, half maximal inhibitory concentration value of Ptx, cell cycle progression, and induced cell apoptosis in Ptx-resistant ovarian cancer cells. miR-508-3p was a target of circSETDB1, and inhibition of miR-508-3p overturned the effects of circSETDB1 knockdown on the Ptx resistance of ovarian cancer cells. miR-508-5p could bind to ABCC1. Overexpression of ABCC1 reversed the effects of circSETDB1 knockdown on the Ptx resistance of ovarian cancer cells. CircSETDB1 knockdown also enhanced Ptx sensitivity in vivo. In conclusion, circSETDB1 regulated Ptx resistance of ovarian cancer by targeting miR-508-3p/ABCC1 axis.

学科与关键词

关键词
ABCC1circSETDB1miR-508-3povarian cancerpaclitaxelresistance
相关
加载中…
  • Circular RNA CDR1as Alleviates Cisplatin-Based Chemoresistance by Suppressing MiR-1299 in Ovarian Cancer
    Wu, Han; Zhao, Xibo; Wang, Jing; Jiang, Xinyan; Cheng, Yan; He, Yanan; Sun, Liyuan; Zhang, Guangmei*Frontiers in Genetics, 2022, 12: 815448.被引 6
  • MiR-181c sensitizes ovarian cancer cells to paclitaxel by targeting GRP78 through the PI3K/Akt pathway
    Zhang, Li-ying; Yu, Jia-ying; Leng, Yan-long; Zhu, Ran-ran; Liu, Hong-xian; Wang, Xin-yu; Yang, Ting-ting; Guo, Yi-ning; Tang, Jing-ling*; Zhang, Xin-chen*Cancer Gene Therapy, 2022, 29(6): 770-783.被引 5
  • MiR-4284 inhibits sensitivity to paclitaxel in human ovarian carcinoma SKOV3ip1 and HeyA8 cells by targeting DMC1
    Sun, Dongyan*; Shang, Di; Miao, Pan; Jiang, Zhihe; Chen, Yanling; Gao, JianAnti-Cancer Drugs, 2022, 33(8): 701-709.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Anti-Cancer Drugs
发表日期
2023-03
卷期
第 34 卷, 第 3 期
页码
395-404
DOI
10.1097/CAD.0000000000001465
语言
ENGLISH
成果收录
SCIE

作者

  • H

    Huang, Chunyan (第一作者)

    wuhan univ sci & technol

  • Q

    Qin, Li

    wuhan univ sci & technol

查看全部 4 位作者收起作者
  • C

    Chen, Sailan

    wuhan univ sci & technol

  • H

    Huang, Qin (通讯)

    1 · wuhan univ sci & technol

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417